Cargando…
Thalidomide Inhibits Human iPSC Mesendoderm Differentiation by Modulating CRBN-dependent Degradation of SALL4
Exposure to thalidomide during a critical window of development results in limb defects in humans and non-human primates while mice and rats are refractory to these effects. Thalidomide-induced teratogenicity is dependent on its binding to cereblon (CRBN), the substrate receptor of the Cul4A-DDB1-CR...
Autores principales: | Belair, David G., Lu, Gang, Waller, Laura E., Gustin, Jason A., Collins, Nathaniel D., Kolaja, Kyle L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046148/ https://www.ncbi.nlm.nih.gov/pubmed/32071327 http://dx.doi.org/10.1038/s41598-020-59542-x |
Ejemplares similares
-
Regulation of AMPK Activity by CRBN Is Independent of the Thalidomide-CRL4(CRBN) Protein Degradation Axis
por: Yang, Seung-Joo, et al.
Publicado: (2021) -
Comparative Genomics Identifies Putative Interspecies Mechanisms Underlying Crbn-Sall4-Linked Thalidomide Embryopathy
por: Kowalski, Thayne Woycinck, et al.
Publicado: (2021) -
Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide
por: Fischer, Eric S., et al.
Publicado: (2014) -
De-Novo Design
of Cereblon (CRBN) Effectors Guided
by Natural Hydrolysis Products of Thalidomide Derivatives
por: Heim, Christopher, et al.
Publicado: (2019) -
Thalidomide Attenuates Mast Cell Activation by Upregulating SHP-1 Signaling and Interfering with the Action of CRBN
por: Chang, Hyeun-Wook, et al.
Publicado: (2023)